Considering the high frequency of GI disturbances in people with PD, and in particular in body-first PD patients (Horsager et al., 2022), it is important to design future studies including such measurements to fully evaluate the impact of host GBA1 genotype on gut physiology. The gene discussed is GBA1; the disease is Parkinson disease.